Alan Kozikowski
Geen lopende functies
Vermogen: 484 605 $ op 31-05-2024
Loopbaan van Alan Kozikowski
Eerdere bekende functies van Alan Kozikowski
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Directeur/Bestuurslid | 31-05-2019 | 07-09-2022 |
| Hoofd Techniek/Wetenschap/O&O | 29-10-2020 | 27-06-2022 | |
| Oprichter | 31-05-2019 | 07-09-2022 | |
| Starwise Therapeutics LLC | Algemeen Directeur | 01-08-2017 | 01-02-2020 |
| President | 01-08-2017 | 01-02-2020 | |
| University of Illinois | Corporate Officer/Principal | 01-07-2013 | 31-07-2017 |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Oprichter | 01-01-2015 | - |
| Georgetown University Medical Center | Corporate Officer/Principal | - | - |
| University of Pittsburgh | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Corporate Officer/Principal | 3 |
| Founder | 2 |
| Director/Board Member | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Starwise Therapeutics LLC | |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Health Technology |
- Beurs
- Insiders
- Alan Kozikowski
- Ervaring
